Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HeartSciences Inc. - Common Stock (NQ:HSCS)

2.690 +0.030 (+1.13%)
Streaming Delayed Price Updated: 9:49 AM EDT, Mar 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,296
Open 2.602
Bid (Size) 2.610 (100)
Ask (Size) 2.770 (100)
Prev. Close 2.660
Today's Range 2.602 - 2.690
52wk Range 2.010 - 6.470
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
From HeartSciences Inc.
Via GlobeNewswire
BioMedNewsBreaks — HeartSciences Inc. (NASDAQ: HSCS; HSCSW) Secures UWE As Exclusive ECG Education Reference Center
Via Investor Brand Network
Topics Artificial Intelligence

Performance

YTD
-14.3%
-14.3%
1 Month
-8.8%
-8.8%
3 Month
+8.9%
+8.9%
6 Month
-18.5%
-18.5%
1 Year
-10.3%
-10.3%

More News

Read More
News headline image
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Inc (NASDAQ:HSCS) Reports Q1 FY2026 Results with Narrower-Than-Expected Loss and Positive Business Updates ↗
Via Chartmill
News headline image
HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Conference Participation and Investor Webinar
From HeartSciences Inc.
Via GlobeNewswire
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results
From HeartSciences Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Presenting on Emerging Growth Conference 82 Day 2 on May 22; Register to live stream ↗
Via Stocktwits
News headline image
HeartSciences Receives FDA Breakthrough Device Designation for MyoVista Insights AI-ECG Algorithm for Detecting Aortic Stenosis
From HeartSciences Inc.
Via GlobeNewswire
News headline image
Foundational US Patent Granted for ECG Assessment of Heart Function, Further Expands HeartSciences’ Patent Portfolio and IP Value
From HeartSciences Inc.
Via GlobeNewswire
News headline image
HeartSciences Signs First MyoVista Insights™ Platform Customer, Marking Major Commercial Milestone
From HeartSciences Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
HeartSciences’ CEO Andrew Simpson to Present at Emerging Growth Conference 82 on Wednesday, May 21, 2025
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences to Host Investor Webinar and Q&A on Wednesday May 14, 2025 - Featuring CEO Andrew Simpson
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Adds Prominent Key Advisors to its Scientific Advisory Board
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program
From Heart Test Laboratories, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga

Frequently Asked Questions

Is HeartSciences Inc. - Common Stock publicly traded?
Yes, HeartSciences Inc. - Common Stock is publicly traded.
What exchange does HeartSciences Inc. - Common Stock trade on?
HeartSciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for HeartSciences Inc. - Common Stock?
The ticker symbol for HeartSciences Inc. - Common Stock is HSCS on the Nasdaq Stock Market
What is the current price of HeartSciences Inc. - Common Stock?
The current price of HeartSciences Inc. - Common Stock is 2.690
When was HeartSciences Inc. - Common Stock last traded?
The last trade of HeartSciences Inc. - Common Stock was at 03/17/26 09:49 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.